electroCore, Inc. Payments to Acquire Marketable Securities
electroCore, Inc. (ECOR) reported Payments to Acquire Marketable Securities of $8.52 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2025-03-12
- electroCore, Inc. payments to acquire marketable securities for the quarter ending 2024-12-31 was $501.00K.
- electroCore, Inc. payments to acquire marketable securities for the quarter ending 2024-09-30 was $4.09M.
- electroCore, Inc. payments to acquire marketable securities for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- electroCore, Inc. payments to acquire marketable securities for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- electroCore, Inc. payments to acquire marketable securities for fiscal 2024 was $8.52M.
- electroCore, Inc. payments to acquire marketable securities for fiscal 2021 was $5.08M, a 79.22% decline from fiscal 2020.
- electroCore, Inc. payments to acquire marketable securities for fiscal 2020 was $24.46M, a 34.28% decline from fiscal 2019.
- electroCore, Inc. payments to acquire marketable securities for fiscal 2019 was $37.22M, a 54.08% decline from fiscal 2018.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $4.59M derived: sum of 2 quarters · filed 2025-03-12 | $8.52M 10-K · filed 2025-03-12 | |||||
| 2024-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $8.02M 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | $3.93M 10-Q · filed 2024-08-07 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $5.08M 10-K · filed 2023-03-08 | $5.08M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $5.08M 10-Q · filed 2022-11-03 | $5.08M 10-Q · filed 2021-11-04 | $7.38M derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.08M 10-Q · filed 2022-08-04 | $5.08M 10-Q · filed 2021-08-05 | $7.38M derived: sum of 3 quarters · filed 2022-08-04 | $25.55M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $5.08M 10-Q · filed 2022-05-05 | $5.08M 10-Q · filed 2021-05-06 | $7.38M derived: sum of 2 quarters · filed 2022-05-05 | $25.55M derived: sum of 3 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $20.46M derived: sum of 2 quarters · filed 2022-03-10 | $24.46M 10-K · filed 2022-03-10 | |||||
| 2020-09-30 | $18.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $22.17M 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | $4.00M 10-Q · filed 2021-08-05 | |||||||
| 2019-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $16.93M derived: sum of 2 quarters · filed 2021-03-11 | $25.11M derived: sum of 3 quarters · filed 2021-03-11 | $37.22M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $14.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $23.11M derived: sum of 2 quarters · filed 2020-11-12 | $35.22M 10-Q · filed 2020-11-12 | $59.69M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $8.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $20.29M 10-Q · filed 2020-08-13 | $44.76M derived: sum of 3 quarters · filed 2020-08-13 | $90.91M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $12.11M 10-Q · filed 2020-05-15 | $36.58M derived: sum of 2 quarters · filed 2020-05-15 | $82.73M derived: sum of 3 quarters · filed 2020-05-15 | $82.74M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $24.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $70.62M derived: sum of 2 quarters · filed 2020-03-30 | $70.63M derived: sum of 3 quarters · filed 2020-03-30 | $81.06M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $46.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $46.16M derived: sum of 2 quarters · filed 2019-11-14 | $56.59M 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $2.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $10.43M 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $10.43M 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $32.43M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |